5.60
Karyopharm Therapeutics Inc (KPTI) 最新ニュース
Karyopharm Therapeutics (NASDAQ:KPTI) Issues Quarterly Earnings Results - MarketBeat
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q3 2025 Earnings Call Transcript - Insider Monkey
RBC Cuts Price Target on Karyopharm Therapeutics to $19 From $30, Keeps Outperform Rating - MarketScreener
What makes Karyopharm Therapeutics Inc. (25K0) stock appealing to growth investorsPortfolio Risk Summary & Long-Term Growth Plans - newser.com
Quantitative breakdown of Karyopharm Therapeutics Inc. recent moveQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - newser.com
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
How Karyopharm Therapeutics Inc. stock compares to industry benchmarksWeekly Trend Summary & Weekly High Return Stock Opportunities - newser.com
Karyopharm Therapeutics: Q3 Earnings Snapshot - New Haven Register
Karyopharm Therapeutics Q3 2025 Earnings Call Transcript - MarketBeat
Karyopharm Therapeutics Reports Q3 2025 Financial Results - TipRanks
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Short Interest Down 36.3% in October - MarketBeat
Karyopharm Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Karyopharm (Nasdaq: KPTI) grants 800 RSUs to new hire, vesting over 3 years - Stock Titan
Karyopharm (KPTI) Reports Strong Q3 2025, Highlights Myelofibros - GuruFocus
Karyopharm Therapeutics Inc. Reaffirms Earnings Guidance for the Full Year 2025 - MarketScreener
Transcript : Karyopharm Therapeutics Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener
Karyopharm Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Earnings call transcript: Karyopharm Q3 2025 shows revenue growth, pre-market dip - Investing.com
How geopolitical tensions affect Karyopharm Therapeutics Inc. stock2025 Historical Comparison & Free Expert Approved Momentum Trade Ideas - newser.com
Karyopharm Grows Revenue With Strong XPOVIO Sales And Partnerships - Finimize
Is Karyopharm Therapeutics Inc. (25K0) stock a top hedge fund pickIPO Watch & Safe Capital Growth Trade Ideas - newser.com
Analyzing net buyer seller activity in Karyopharm Therapeutics Inc.July 2025 Final Week & High Accuracy Trade Signal Alerts - newser.com
Karyopharm (KPTI) Surpasses Q3 Revenue Expectations with Clinica - GuruFocus
Karyopharm (KPTI) Projects Revenue Growth and Expense Reduction for FY25 - GuruFocus
Is Karyopharm Therapeutics Inc. stock safe for conservative investorsQuarterly Trade Summary & Verified Short-Term Plans - newser.com
Karyopharm Therapeutics Inc. SEC 10-Q Report - TradingView
Karyopharm Therapeutics' Q3 net loss widens - TradingView
Karyopharm Reports Third Quarter 2025 Financial Results and Highlights Recent Company Progress - PR Newswire
Will Karyopharm Therapeutics Inc. stock gain from strong economyQuarterly Portfolio Summary & Community Consensus Trade Signals - newser.com
How Karyopharm Therapeutics Inc. (25K0) stock reacts to new regulationsQuarterly Market Review & Verified Technical Trade Signals - newser.com
Karyopharm Therapeutics Inc. stock trend outlook and recovery path2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - newser.com
Is it time to cut losses on Karyopharm Therapeutics Inc.July 2025 EndofMonth & Weekly Setup with High ROI Potential - newser.com
Using Ichimoku Cloud for Karyopharm Therapeutics Inc. technicalsPortfolio Risk Summary & Low Drawdown Trading Techniques - newser.com
Will Karyopharm Therapeutics Inc. outperform the marketM&A Rumor & Safe Entry Trade Reports - newser.com
Technical signs of recovery in Karyopharm Therapeutics Inc.July 2025 Technicals & Verified Momentum Stock Watchlist - newser.com
Is Karyopharm Therapeutics Inc. (25K0) stock cheap vs fundamentalsMarket Performance Summary & Fast Entry High Yield Stock Tips - newser.com
Will Karyopharm Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Drop Watch & Growth Focused Stock Reports - newser.com
Can Karyopharm Therapeutics Inc. stock continue upward trendChart Signals & Fast Exit and Entry Trade Guides - newser.com
Is Karyopharm Therapeutics Inc. stock vulnerable to regulatory risksWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com
大文字化:
|
ボリューム (24 時間):